Skip to main content

Table 2 Baseline haemodynamic and metabolic data in patients with COPD and controls

From: Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

 

Controls n = 20

Patients n = 32

p value

Aortic PWV (m/s)

8.5 (1.4)

9.8 (2.7)

<0.05

Brachial PWV (m/s)

8.5 (1.2)

9.0 (1.7)

0.329

AIx (%)

26.9 (15.9)

32.3 (8.4)

0.156

Peripheral SBP (mmHg)

130 (16)

138 (19)

0.135

Peripheral DBP (mmHg)

79 (8)

82 (9)

0.247

Peripheral PP (mmHg)

51 (13)

56 (15)

0.196

Peripheral MAP (mmHg)

96 (10)

100 (11)

0.177

Central SBP (mmHg)

120 (16)

125 (18)

0.368

Central DBP (mmHg)

80 (8)

82 (11)

0.621

Central PP (mmHg)

40 (12)

47 (18)

0.133

Central MAP (mmHg)

97 (10)

104 (13)

0.055

Heart rate (bpm)

68 (11)

77 (12)

<0.01

Fasting Glucose (mmol/L)

5.2 (0.5)

5.0 (0.6)

0.236

Total Fasting Cholesterol (mmol/L)

5.2 (1.2)

5.6 (1.2)

0.360

LDL (mmol/L)

3.0 (1.2)

3.3 (1.1)

0.322

HDL (mmol/L)

1.6 (0.7)

1.7 (0.5)

0.504

Cholesterol/HDL ratio

3.8 (1.5)

3.5 (1.0)

0.373

Triglyceride (mmol/L)

1.2 (0.6)

1.1 (0.4)

0.591

IL-6 † (pg/ml)

1.3 (3.1)

3.8 (2.1)

<0.001

  1. Data presented as mean (SD), unless otherwise stated, † = Geometric mean.
  2. Abbreviations: AIx = augmentation index; DBP= diastolic blood pressure; HDL = high-density lipoprotein; IL-6 = interleukin 6; LDL = low-density lipoprotein; MAP = mean arterial pressure; PP = pulse pressure; PWV = pulse wave velocity; SBP = systolic blood pressure.